Breakthroughs in Rapid Diagnostics and Susceptibility Testing for CRE and MBL Infections

Breakthroughs in Rapid Diagnostics and Susceptibility Testing for CRE and MBL Infections

Tuesday, April 28th 2026 - 2:45 PM (IST)

23 days to go

415 doctors attending

Tuesday, April 28th 2026 - 2:45 PM (IST)

Medflix

About this session

Dr. Balaji Veeraraghavan leads this forward-looking session on the transformative role of rapid diagnostics in managing carbapenem-resistant Enterobacterales (CRE) and metallo-beta-lactamase (MBL) infections. The discussion delves into cutting-edge diagnostic technologies and advanced susceptibility testing approaches that enable early detection, guide precision therapy, and improve clinical outcomes in high-risk ICU patients.

Faculty

Key details

Registration

Free

Duration

30 min

Replay

Yes

Certificate

No

Language

English

Explore other sessions

AI in Daily Practice: A Doctor’s Starter Kit

AI in Daily Practice: A Doctor’s Starter Kit

7 April 2026 | 3:30 PM (IST)